BriaCell Therapeutics - Warrants (24/02/2025) Overview

BriaCell Therapeutics - Warrants (24/02/2025) Selling, General & Admin

Selling, General & Admin expenses for BCTXW.

Quarterly SG&A Expenses

$1.65M

↑ 8.96% YoY

As of Apr 30, 2026

Annual SG&A Expenses (TTM)

$6.22M

↑ 6.19% YoY

Trailing 12 months ending Apr 30, 2026

Average SG&A Expenses (Comparison Companies)

Selling, General & Admin History

Selling, General & Admin Comparison

Annual Selling, General & Admin Growth Rate (%)

Annual Selling, General & Admin Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin